Clinical Trial Update: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating safety and efficacy for YZJ-1139 in insomnia disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• YZJ-1139

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Insomnia Disorder | Phase 3 | Status: RECRUITING